Quick Summary

• Gabapentin is widely prescribed. It is FDA-approved for certain seizure disorders and postherpetic neuralgia.
• Cognitive side effects are documented. Public drug information and prescribing information list effects that can impact thinking, alertness, and memory for some patients.
• Dementia-risk claims are allegations that require proof. Some research has explored whether there is an association between gabapentin use and dementia risk, but research does not automatically prove causation. Your case depends on your medical facts and records.

What Is Gabapentin (Neurontin®)?

Gabapentin is a prescription medication. Neurontin® is a brand-name version historically associated with Pfizer/Warner-Lambert. Many patients today receive generic gabapentin. Regardless of whether the case is brand or generic, the case review usually focuses on the specific product taken, what the patient was told, and whether warnings and risk screening were adequate.

Cognitive Impairment: Symptoms Families Often Report

Families who contact us often describe new changes, worsening, or unexpected after starting gabapentin or after a dose increase, including:

• New or worsening confusion
• Memory problems
• Difficulty concentrating
• Slowed thinking or “brain fog”
• Getting lost, missing appointments, or major changes in daily functioning
• Sudden functional decline in an older adult

These symptoms can have many causes. A legal review looks at whether gabapentin was a plausible contributing factor and whether the risks were appropriately communicated.

Gabapentin and Dementia: What a Legal Review Looks At

You may see statements online that gabapentin “causes dementia.” The reality is more complex. Some studies have examined whether gabapentin use is associated with an increased risk of dementia or cognitive decline in certain populations. Association is not the same as proof of causation, and each person’s medical situation is different. In a potential gabapentin lawsuit against Pfizer (or other responsible entities, depending on the product), the key questions are often:

• What was known (or should have been known) about cognitive risks at the time?
• Were patients and prescribers adequately warned?
• Were higher-risk patients identified and monitored?
• Does the timeline support a connection between gabapentin exposure and cognitive decline?
• Are there alternative explanations (stroke, Alzheimer’s disease, Parkinson’s, medication interactions, untreated sleep apnea, alcohol use, etc.)?

Who May Want a Case Evaluation?

You may want to contact Oliver Bell Group if you or a loved one:

• Took gabapentin (Neurontin® or generic) and then developed significant cognitive
  impairment
• Was diagnosed with mild cognitive impairment (MCI) or dementia after a period of gabapentin use
• Experienced rapid decline after starting gabapentin or after a major dose change
• Is an older adult who had new confusion, falls, or loss of independence while taking gabapentin
• Was not warned about cognitive side effects, sedation, or impacts on alertness and thinking

Case Factors

Our team focuses on records and timelines, including:

• Prescription history: product type (brand vs. generic), dose, refill history, changes over time
• Medical timeline: when cognitive symptoms started and how they progressed
• Other medications: especially sedating drugs that can worsen cognition
• Risk factors: age, kidney function, prior neurological issues, sleep disorders, substance use history
• Diagnosis evidence: neurology notes, cognitive testing, imaging summaries, hospitalization records
• Warnings and counseling: what the patient received and what the prescriber discussed

Trust Our Firm: Oliver Bell Group

We know families come to us worried and overwhelmed. Our job is to evaluate the facts, explain what they may support, and help you decide the next steps.

• Evidence-driven: We rely on records, not internet rumors.
• Clear communication: We explain what strengthens a claim and what may be missing.
• Respectful process: We treat every family’s situation with care.

Contact Oliver Bell Group

If you believe gabapentin may be linked to dementia or cognitive impairment in your family, we can help you understand whether a claim may be worth pursuing. We have stood up to Pfizer before and are not afraid of corporate giants.

Contact Oliver Bell Group for a confidential case evaluation.

FAQ

Is there a gabapentin lawsuit in 2026?
Possibly. Some cases are filed individually, and some litigation may be coordinated depending on what claims are being filed and where. Eligibility depends on your medical facts and documentation.

Does gabapentin cause dementia?
Some research has explored a possible association between gabapentin use and dementia risk in certain groups, but an association does not prove causation. A legal case typically requires strong medical and timeline evidence, plus proof related to warnings and responsibility.

Should I stop taking gabapentin if I’m worried?
No. Do not stop taking gabapentin without medical guidance. MedlinePlus warns that stopping suddenly can increase seizure risk for some patients.

This page is for legal information only and is not medical advice. For medical symptoms, medication changes, or emergencies, contact a licensed healthcare professional or emergency services immediately.